p53 transcription factor assay kit

Thursday, 01 January, 2009 | Supplied by: Sapphire Bioscience

Cayman’s p53 Transcription Factor Assay is a non-radioactive, sensitive method for detecting specific transcription factor DNA binding activity in nuclear extracts.

A specific double stranded DNA sequence containing the p53 response element is immobilised onto the wells of a 96-well plate. A nuclear extract containing p53 binds specifically to the p53 response element and is detected by addition of a specific primary antibody.

A secondary antibody conjugated to HRP is added to provide a sensitive colorimetric readout at 450 nm.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Content from other channels on our network

Bulla Dairy Foods selects AI platform for its contracting operations

GEA and CST partner to improve sugar processing efficiency

Proactive approach for detecting counterfeit alcohol could save lives

Food technologies on show at foodpro 2026

Why food manufacturing needs a digital backbone

Partnered Health responds to malicious actor incident

Revised Criminal History Registration Standard now in effect

Children's Health Queensland HHS makes statement as part of settlement

Webinar to delve into mobile connectivity in health and aged care

A Day in the Life of a social worker specialising in FASD

Monash University launches critical minerals initiative

TeamViewer brings AI to remote assistance AR for frontline workers

Belden and Tulip partner to gather data from legacy equipment

Energy and manufacturing future for two Hunter coal sites

Claroty and Frenos partner to reduce OT downtime risk

p53 transcription factor assay kit

Invent Biotechnologies Minute Single Cell Nuclei Kits

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution

Enzo Life Sciences Histamine ELISA Kit

Content from other channels on our network